Pyxis Oncology, Inc. (PYXS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$84.42M | +5.6% |
| 2024 | -$89.46M | -8.8% |
| 2023 | -$82.20M | +33.4% |
| 2022 | -$123.48M | -77.1% |
| 2021 | -$69.72M | -440.7% |
| 2020 | -$12.89M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$84.42M | +5.6% |
| 2024 | -$89.46M | -8.8% |
| 2023 | -$82.20M | +33.4% |
| 2022 | -$123.48M | -77.1% |
| 2021 | -$69.72M | -440.7% |
| 2020 | -$12.89M | — |